|
|
41
|
|
|
31716
|
|
|
HYRIMOZ 40MG INJ (BCH) ADALIMUMAB (C)
|
|
|
ADALIMUMAB
|
|
|
HYRIMOZ
|
|
|
2X40MG
|
|
|
C
|
|
|
1202.04
|
|
|
601.0214
|
|
|
40MG
|
|
|
BOX
|
|
|
0
|
|
|
PFS
|
|
|
BCH
|
|
|
SANDOZ
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
|
|
|
2024-04-01
|
|
|
2026-03-31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
N
|
|
|
9236
|
|
|
DISEASE MODIFYING ANTIRHEUMATIC AGENTS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
DISEASE MODIFYING ANTIRHEUMATIC AGENTS
|
|
|
|